AI Verdict
MYE has stronger fundamentals based on our AI analysis.
MYGN vs MYE Fundamental Comparison
| Metric | MYGN | MYE |
|---|---|---|
| Revenue | $824.5M | $825.7M |
| Net Income | $-365.9M | $34.9M |
| Net Margin | -44.4% | 4.2% |
| ROE | -99.4% | 11.9% |
| ROA | -51.8% | 4.1% |
| Current Ratio | 2.49x | 1.67x |
| Debt/Equity | 0.33x | 1.18x |
| EPS | $-3.95 | $0.93 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MYGN vs MYE: Frequently Asked Questions
Is MYGN or MYE a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MYE has stronger fundamentals. MYGN is rated STRONG SELL (87% confidence) while MYE is rated HOLD (72% confidence). This is not investment advice.
How does MYGN compare to MYE fundamentally?
MYRIAD GENETICS INC has ROE of -99.4% vs MYERS INDUSTRIES INC's 11.9%. Net margins are -44.4% vs 4.2% respectively.
Which stock pays higher dividends, MYGN or MYE?
MYGN has a dividend yield of N/A or no dividend while MYE has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MYGN or MYE for long term?
For long-term investing, consider that MYGN has STRONG SELL rating with 87% confidence, while MYE has HOLD rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MYGN vs MYE?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MYGN vs MYE, the AI consensus favors MYE based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.